W Stephen Holmes - Net Worth and Insider Trading
W Stephen Holmes Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, W Stephen Holmes owns 14 companies in total, including Venus Concept Inc (VERO) , Obalon Therapeutics Inc (OBLN) , and Eiger BioPharmaceuticals Inc (EIGRQ) among others .
Click here to see the complete history of W Stephen Holmes’s form 4 insider trades.
Insider Ownership Summary of W Stephen Holmes
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
VERO | Venus Concept Inc | 2017-10-11 | 10 percent owner |
OBLN | Obalon Therapeutics Inc | 2016-10-12 | 10 percent owner |
EIGRQ | Eiger BioPharmaceuticals Inc | 2016-03-22 | 10 percent owner & other: affiliate |
2015-06-24 | 10 percent owner | ||
2015-06-18 | 10 percent owner | ||
2015-04-08 | 10 percent owner | ||
2014-05-29 | 10 percent owner | ||
2014-03-26 | 10 percent owner | ||
2013-10-09 | 10 percent owner | ||
2013-08-05 | other: Former 10% Owner | ||
2011-09-20 | 10 percent owner | ||
2008-04-16 | 10 percent owner | ||
2007-11-20 | 10 percent owner | ||
2016-10-05 | 10 percent owner |
W Stephen Holmes Trading Performance
W Stephen Holmes Ownership Network
W Stephen Holmes Owned Company Details
What does Venus Concept Inc do?
Who are the key executives at Venus Concept Inc?
W Stephen Holmes is the 10 percent owner of Venus Concept Inc. Other key executives at Venus Concept Inc include 10 percent owner Michael Willingham Masters , President Global Sales Ross Portaro , and 10 percent owner Masters Special Situations, Llc .
Venus Concept Inc (VERO) Insider Trades Summary
Over the past 18 months, W Stephen Holmes made no insider transaction in Venus Concept Inc (VERO). Other recent insider transactions involving Venus Concept Inc (VERO) include a net sale of 489,948 shares made by Michael Willingham Masters ,
In summary, during the past 3 months, insiders sold 0 shares of Venus Concept Inc (VERO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 489,948 shares of Venus Concept Inc (VERO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 489,948 shares.
Venus Concept Inc (VERO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Venus Concept Inc Insider Transactions
- Download to Excel(.xls)
What does Obalon Therapeutics Inc do?
Who are the key executives at Obalon Therapeutics Inc?
W Stephen Holmes is the 10 percent owner of Obalon Therapeutics Inc. Other key executives at Obalon Therapeutics Inc include director & President & CEO & Exec Chairman Andrew P Rasdal , Chief Financial Officer Nooshin Hussainy , and Chief Technology Officer Mark Brister .
Obalon Therapeutics Inc (OBLN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Obalon Therapeutics Inc (OBLN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Obalon Therapeutics Inc (OBLN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Obalon Therapeutics Inc (OBLN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Obalon Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Eiger BioPharmaceuticals Inc do?
Who are the key executives at Eiger BioPharmaceuticals Inc?
W Stephen Holmes is the 10 percent owner & other: affiliate of Eiger BioPharmaceuticals Inc. Other key executives at Eiger BioPharmaceuticals Inc include 10 percent owner Richard A Kayne , 10 percent owner Leen Kawas , and Chief Business Officer Ingrid Choong .
Eiger BioPharmaceuticals Inc (EIGRQ) Insider Trades Summary
Over the past 18 months, W Stephen Holmes made no insider transaction in Eiger BioPharmaceuticals Inc (EIGRQ). Other recent insider transactions involving Eiger BioPharmaceuticals Inc (EIGRQ) include a net purchase of 278,239 shares made by Richard A Kayne , and a net purchase of 24,332 shares made by Leen Kawas .
In summary, during the past 3 months, insiders sold 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) were sold and 10,086 shares were bought by its insiders, resulting in a net purchase of 10,086 shares.
Eiger BioPharmaceuticals Inc (EIGRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eiger BioPharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Glaukos Corp do?
Who are the key executives at Glaukos Corp?
W Stephen Holmes is the 10 percent owner of Glaukos Corp. Other key executives at Glaukos Corp include CFO & SVP Corporate Development Joseph E Gilliam , SVP & Chief Financial Officer Alex R. Thurman , and director & 10 percent owner & Chief Executive Officer Thomas William Burns .
Glaukos Corp (GKOS) Insider Trades Summary
Over the past 18 months, W Stephen Holmes made no insider transaction in Glaukos Corp (GKOS). Other recent insider transactions involving Glaukos Corp (GKOS) include a net sale of 309,154 shares made by Joseph E Gilliam , a net sale of 520,000 shares made by Thomas William Burns , and a net sale of 6,762 shares made by Alex R. Thurman .
In summary, during the past 3 months, insiders sold 41,500 shares of Glaukos Corp (GKOS) in total and bought 0 shares, with a net sale of 41,500 shares. During the past 18 months, 939,823 shares of Glaukos Corp (GKOS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 939,823 shares.
Glaukos Corp (GKOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Glaukos Corp Insider Transactions
- Download to Excel(.xls)
What does Invuity Inc do?
Who are the key executives at Invuity Inc?
W Stephen Holmes is the 10 percent owner of Invuity Inc. Other key executives at Invuity Inc include Chief Financial Officer James H Mackaness , 10 percent owner & other: Possible Member of 10% Group James E Flynn , and 10 percent owner & other: Possible Member of 10% Group Deerfield Management Company, L.p. (series C) .
Invuity Inc (IVTY) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Invuity Inc (IVTY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Invuity Inc (IVTY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Invuity Inc (IVTY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Invuity Inc Insider Transactions
- Download to Excel(.xls)
What does KalVista Pharmaceuticals Inc do?
Who are the key executives at KalVista Pharmaceuticals Inc?
W Stephen Holmes is the 10 percent owner of KalVista Pharmaceuticals Inc. Other key executives at KalVista Pharmaceuticals Inc include CFO and Secretary Benjamin L Palleiko , Chief Medical Officer Paul K. Audhya , and Chief Development Officer Christopher Yea .
KalVista Pharmaceuticals Inc (KALV) Insider Trades Summary
Over the past 18 months, W Stephen Holmes made no insider transaction in KalVista Pharmaceuticals Inc (KALV). Other recent insider transactions involving KalVista Pharmaceuticals Inc (KALV) include a net purchase of 1,251,017 shares made by Venrock Healthcare Capital Partners Iii, L.p. , a net sale of 144,760 shares made by Benjamin L Palleiko , and a net sale of 116,267 shares made by Edward P. Feener .
In summary, during the past 3 months, insiders sold 40,693 shares of KalVista Pharmaceuticals Inc (KALV) in total and bought 0 shares, with a net sale of 40,693 shares. During the past 18 months, 583,370 shares of KalVista Pharmaceuticals Inc (KALV) were sold and 1,251,017 shares were bought by its insiders, resulting in a net purchase of 667,647 shares.
KalVista Pharmaceuticals Inc (KALV)'s detailed insider trading history can be found in Insider Trading Tracker table.
KalVista Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Marketo Inc do?
Who are the key executives at Marketo Inc?
W Stephen Holmes is the 10 percent owner of Marketo Inc. Other key executives at Marketo Inc include SVP & Chief Financial Officer Brian K Kinion , EVP Worldwide Field Operations Steven M Winter , and SVP & GC & Secretary Margo Smith .
Marketo Inc (MKTO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Marketo Inc (MKTO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Marketo Inc (MKTO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Marketo Inc (MKTO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Marketo Inc Insider Transactions
- Download to Excel(.xls)
What does Applied Genetic Technologies Corp do?
Who are the key executives at Applied Genetic Technologies Corp?
W Stephen Holmes is the 10 percent owner of Applied Genetic Technologies Corp. Other key executives at Applied Genetic Technologies Corp include Chief Medical Officer Susan Schneider , Chief Financial Officer Jonathan I Lieber , and See Remarks Stephen W Potter .
Applied Genetic Technologies Corp (AGTC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Applied Genetic Technologies Corp (AGTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Applied Genetic Technologies Corp (AGTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Applied Genetic Technologies Corp (AGTC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Applied Genetic Technologies Corp Insider Transactions
- Download to Excel(.xls)
What does Macrogenics Inc do?
Who are the key executives at Macrogenics Inc?
W Stephen Holmes is the 10 percent owner of Macrogenics Inc. Other key executives at Macrogenics Inc include Acting General Counsel Jeffrey Stuart Peters , SVP & CFO and Secretary James Karrels , and Sr VP & BPD & Manufacturing Thomas Spitznagel .
Macrogenics Inc (MGNX) Insider Trades Summary
Over the past 18 months, W Stephen Holmes made no insider transaction in Macrogenics Inc (MGNX). Other recent insider transactions involving Macrogenics Inc (MGNX) include a net sale of 163,395 shares made by Jeffrey Stuart Peters , a net sale of 48,846 shares made by Ezio Bonvini , and a net purchase of 350,000 shares made by Biotech Target N V .
In summary, during the past 3 months, insiders sold 0 shares of Macrogenics Inc (MGNX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 293,400 shares of Macrogenics Inc (MGNX) were sold and 365,000 shares were bought by its insiders, resulting in a net purchase of 71,600 shares.
Macrogenics Inc (MGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Macrogenics Inc Insider Transactions
- Download to Excel(.xls)
What does Tesaro Inc do?
Who are the key executives at Tesaro Inc?
W Stephen Holmes is the other: Former 10% Owner of Tesaro Inc. Other key executives at Tesaro Inc include director & President & COO Mary Lynne Hedley , SVP & Chief Medical Officer Huber Martin H. Jr. , and director & Chief Executive Officer Moulder Leon O Jr .
Tesaro Inc (TSRO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Tesaro Inc (TSRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tesaro Inc (TSRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Tesaro Inc (TSRO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tesaro Inc Insider Transactions
- Download to Excel(.xls)
What does Paratek Pharmaceuticals Inc do?
Who are the key executives at Paratek Pharmaceuticals Inc?
W Stephen Holmes is the 10 percent owner of Paratek Pharmaceuticals Inc. Other key executives at Paratek Pharmaceuticals Inc include CLO & General Counsel & Sec. William M. Haskel , President & Chief Commercial Adam Woodrow , and Chief Development & Regulatory Randall B. Brenner .
Paratek Pharmaceuticals Inc (PRTK) Insider Trades Summary
Over the past 18 months, W Stephen Holmes made no insider transaction in Paratek Pharmaceuticals Inc (PRTK). Other recent insider transactions involving Paratek Pharmaceuticals Inc (PRTK) include a net purchase of 788,500 shares made by James D Dondero , a net sale of 48,967 shares made by Evan Loh , and a net sale of 34,526 shares made by William M. Haskel .
In summary, during the past 3 months, insiders sold 0 shares of Paratek Pharmaceuticals Inc (PRTK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 142,346 shares of Paratek Pharmaceuticals Inc (PRTK) were sold and 788,500 shares were bought by its insiders, resulting in a net purchase of 646,154 shares.
Paratek Pharmaceuticals Inc (PRTK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Paratek Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Metabasis Therapeutics Inc do?
Who are the key executives at Metabasis Therapeutics Inc?
W Stephen Holmes is the 10 percent owner of Metabasis Therapeutics Inc. Other key executives at Metabasis Therapeutics Inc include 10 percent owner Mpm Asset Management Investors 2000b Llc , 10 percent owner Mpm Bioventures Ii Lp , and 10 percent owner Mpm Asset Management Ii Llc .
Metabasis Therapeutics Inc (LGNZZ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Metabasis Therapeutics Inc (LGNZZ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Metabasis Therapeutics Inc (LGNZZ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Metabasis Therapeutics Inc (LGNZZ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Metabasis Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Reshape Lifesciences Inc do?
Who are the key executives at Reshape Lifesciences Inc?
W Stephen Holmes is the 10 percent owner of Reshape Lifesciences Inc. Other key executives at Reshape Lifesciences Inc include Chief Financial Officer Thomas Stankovich , President and CEO Barton P. Bandy , and director & Chairman & President and CEO Dan W Gladney .
Reshape Lifesciences Inc (RSLS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Reshape Lifesciences Inc (RSLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Reshape Lifesciences Inc (RSLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Reshape Lifesciences Inc (RSLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Reshape Lifesciences Inc Insider Transactions
- Download to Excel(.xls)
What does Reshape Lifesciences Inc do?
Who are the key executives at Reshape Lifesciences Inc?
W Stephen Holmes is the 10 percent owner of Reshape Lifesciences Inc. Other key executives at Reshape Lifesciences Inc include Chief Financial Officer Thomas Stankovich , director & President and CEO Paul F. Hickey , and 10 percent owner Steven Boyd .
Reshape Lifesciences Inc (RSLS) Insider Trades Summary
Over the past 18 months, W Stephen Holmes made no insider transaction in Reshape Lifesciences Inc (RSLS). Other recent insider transactions involving Reshape Lifesciences Inc (RSLS) include a net purchase of 16,686 shares made by Thomas Stankovich ,
In summary, during the past 3 months, insiders sold 0 shares of Reshape Lifesciences Inc (RSLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,016 shares of Reshape Lifesciences Inc (RSLS) were sold and 17,702 shares were bought by its insiders, resulting in a net purchase of 16,686 shares.
Reshape Lifesciences Inc (RSLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Reshape Lifesciences Inc Insider Transactions
- Download to Excel(.xls)
W Stephen Holmes Mailing Address
Above is the net worth, insider trading, and ownership report for W Stephen Holmes. You might contact W Stephen Holmes via mailing address: C/o Interwest Partners, 2710 Sand Hill Road, Suite 200, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey